SANDRENA

This brand name is authorized in Australia, Brazil, United Kingdom

Active ingredients

The drug SANDRENA contains one active pharmaceutical ingredient (API):

1 Estradiol
UNII 4TI98Z838E - ESTRADIOL

Estradiol, is chemically and biologically identical to endogenous human estradiol. It substitutes for the loss of oestrogen production in menopausal women, and alleviates menopausal symptoms. Oestrogens prevent bone loss following menopause or ovariectomy.

Read about Estradiol

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
SANDRENA Gel Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G03CA03 Estradiol G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain
Discover more medicines within G03CA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 8286D
Country: BR Cรขmara de Regulaรงรฃo do Mercado de Medicamentos Identifier(s): 527303501166318, 527303502162316
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 36580, 36588, 36590

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.